Industries · Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Biological Products (No Diagnostic Substances)
Top biotechnology: biological products (no diagnostic substances) companies by market capitalization, ranked. Click through for real-time filings and ratings on any ticker. 248 companies tracked.
- 1AMGNAmgen Inc.$230.37B
- 2GILDGilead Sciences Inc.$190.38B
- 3MRNAModerna Inc.$90.35B
- 4ARGXargenx SE$50.79B
- 5RVMDRevolution Medicines Inc.$41.48B
- 6BIIBBiogen Inc.$34.40B
- 7SGENSeagen Inc.$23.34B
- 8BNTXBioNTech SE$22.27B
- 9EXELExelixis Inc.$15.11B
- 10NBIXNeurocrine Biosciences Inc.$13.82B
- 11HALOHalozyme Therapeutics Inc.$13.26B
- 12TECHBio-Techne Corp$11.37B
- 13XLRNAcceleron Pharma Inc.$10.93B
- 14IBRXImmunityBio Inc.$10.50B
- 15APGEApogee Therapeutics Inc.$10.22B
- 16TWSTTwist Bioscience Corporation$9.82B
- 17KRYSKrystal Biotech Inc.$9.79B
- 18QGENQiagen N.V.$9.39B
- 19KYMRKymera Therapeutics Inc.$8.88B
- 20RGENRepligen Corporation$8.72B
- 21ACLXArcellx Inc.$6.73B
- 22IOVAIovance Biotherapeutics Inc.$6.44B
- 23IMVTImmunovant Inc.$5.76B
- 24CGONCG Oncology Inc.$5.48B
- 25KODKodiak Sciences Inc$5.10B
- 26CRSPCRISPR Therapeutics AG$4.86B
- 27SRRKScholar Rock Holding Corporation$4.82B
- 28ABCMAbcam plc$4.59B
- 29ADPTAdaptive Biotechnologies Corporation$4.09B
- 30RLAYRelay Therapeutics Inc.$3.74B
- 31TARSTarsus Pharmaceuticals Inc.$3.56B
- 32DNLIDenali Therapeutics Inc.$2.86B
- 33SWTXSpringWorks Therapeutics Inc.$2.59B
- 34BEAMBeam Therapeutics Inc.$2.44B
- 35ADMAADMA Biologics Inc$2.32B
- 36NVAXNovavax Inc.$2.08B
- 37VCELVericel Corporation$2.06B
- 38BCRXBioCryst Pharmaceuticals Inc.$2.06B
- 39ALVOAlvotech$2.02B
- 40RXRXRecursion Pharmaceuticals Inc.$2.00B
- 41MESOMesoblast Limited$1.79B
- 42VIRVir Biotechnology Inc.$1.76B
- 43NSTGNanoString Technologies Inc.$1.48B
- 44IMCRImmunocore Holdings plc$1.46B
- 45MAZEMaze Therapeutics Inc.$1.46B
- 46INBXInhibrx Biosciences Inc.$1.25B
- 47ITOSiTeos Therapeutics Inc.$1.23B
- 48TSHATaysha Gene Therapies Inc.$1.14B
- 49VORVor Biopharma Inc.$1.11B
- 50REPLReplimune Group Inc.$1.07B
- 51IMTXImmatics N.V.$1.05B
- 52MGTXMeiraGTx Holdings plc$903.8M
- 53CGEMCullinan Therapeutics Inc.$877.8M
- 54GLUEMonte Rosa Therapeutics Inc.$839.5M
- 55DNAGinkgo Bioworks Holdings Inc.$741.8M
- 56SANASana Biotechnology Inc.$697.5M
- 57CADLCandel Therapeutics Inc.$694.0M
- 58FDMT4D Molecular Therapeutics Inc.$674.0M
- 59AURAAura Biosciences Inc.$639.9M
- 60SOPHSOPHiA GENETICS SA$601.0M
- 61ADAPAdaptimmune Therapeutics plc$593.1M
- 62SLDBSolid Biosciences Inc.$586.0M
- 63VXRTVaxart Inc$576.0M
- 64RUBYRubius Therapeutics Inc.$574.2M
- 65PRMEPrime Medicine Inc.$567.7M
- 66VALNValneva SE$537.1M
- 67BLUEbluebird bio Inc.$527.9M
- 68DBVTDBV Technologies S.A.$525.2M
- 69OMGAOmega Therapeutics Inc.$494.5M
- 70ALVRAlloVir Inc.$479.4M
- 71RGNXREGENXBIO Inc.$454.2M
- 72AUTLAutolus Therapeutics plc$449.8M
- 73ALLOAllogene Therapeutics Inc.$449.1M
- 74PROKProKidney Corp.$444.4M
- 75ENTXEntera Bio Ltd.$434.8M
- 76AGMBAgomAb Therapeutics NV$428.0M
- 77ZURAZura Bio Limited$422.6M
- 78VIGLVigil Neuroscience Inc.$414.1M
- 79TECXTectonic Therapeutic Inc.$409.8M
- 80FNCHFinch Therapeutics Group Inc.$385.5M
- 81EIKNEikon Therapeutics Inc.$379.7M
- 82ATHAAthira Pharma Inc.$373.5M
- 83KYTXKyverna Therapeutics Inc.$351.6M
- 84FENCFennec Pharmaceuticals Inc.$349.6M
- 85EDITEditas Medicine Inc.$348.6M
- 86GLSGelesis Holdings Inc.$341.6M
- 87IKNAIkena Oncology Inc.$339.0M
- 88GRTSGritstone bio Inc.$336.5M
- 89FUSNFusion Pharmaceuticals Inc.$330.7M
- 90AERIAerie Pharmaceuticals Inc.$327.7M
- 91CCCCC4 Therapeutics Inc.$321.1M
- 92OPTOpthea Limited$314.4M
- 93ORTXOrchard Therapeutics plc$308.4M
- 94AGENAgenus Inc.$293.6M
- 95ARTVArtiva Biotherapeutics Inc.$288.9M
- 96PSTXPoseida Therapeutics Inc.$288.8M
- 97OCGNOcugen Inc.$285.3M
- 98FLAGFirst Light Acquisition Group Inc.$282.6M
- 99SRZNSurrozen Inc.$279.1M
- 100CABACabaletta Bio Inc.$274.7M
- 101PALIPalisade Bio Inc.$257.9M
- 102IKTInhibikase Therapeutics Inc.$251.2M
- 103IPSCCentury Therapeutics Inc.$249.9M
- 104XFORX4 Pharmaceuticals Inc.$242.9M
- 105FATEFate Therapeutics Inc.$232.5M
- 106LCTXLineage Cell Therapeutics Inc.$232.0M
- 107SABSSAB Biotherapeutics Inc.$226.6M
- 108LXEOLexeo Therapeutics Inc.$215.8M
- 109PLXProtalix BioTherapeutics Inc. (DE)$210.3M
- 110ALECAlector Inc.$209.9M
- 111CGENCompugen Ltd.$189.2M
- 112ARYDARYA Sciences Acquisition Corp IV$189.0M
- 113IVVDInvivyd Inc.$179.2M
- 114CRTXCortexyme Inc.$178.7M
- 115STROSutro Biopharma Inc.$174.4M
- 116VCKAVickers Vantage Corp. I$174.1M
- 117GMDAGamida Cell Ltd.$173.7M
- 118GNFTGENFIT S.A.$171.9M
- 119VECTVectivBio Holding AG$171.1M
- 120DTILPrecision BioSciences Inc.$166.4M
- 121CHRSCoherus Oncology Inc.$162.2M
- 122ERYPErytech Pharma S.A.$160.1M
- 123IPHAInnate Pharma S.A. ADS$159.7M
- 124CMPXCompass Therapeutics Inc.$158.3M
- 125ADVMAdverum Biotechnologies Inc.$152.1M
- 126TARAProtara Therapeutics Inc.$146.6M
- 127SURFSurface Oncology Inc.$138.5M
- 128AVXLAnavex Life Sciences Corp.$138.1M
- 129CRDLCardiol Therapeutics Inc.$137.6M
- 130MOLNMolecular Partners AG$136.9M
- 131EIGREiger BioPharmaceuticals Inc.$133.5M
- 132ABOSAcumen Pharmaceuticals Inc.$126.2M
- 133VYGRVoyager Therapeutics Inc.$123.9M
- 134TCRRTCR2 Therapeutics Inc.$123.1M
- 135ADOCEdoc Acquisition Corp.$121.0M
- 136LJPCLa Jolla Pharmaceutical Company$120.0M
- 137FRLNFreeline Therapeutics Holdings plc$116.7M
- 138OTLKOutlook Therapeutics Inc.$114.5M
- 139BCLIBrainstorm Cell Therapeutics Inc.$111.4M
- 140LENZLENZ Therapeutics Inc.$107.8M
- 141APTOAptose Biosciences Inc.$106.7M
- 142ENGNenGene Therapeutics Inc.$104.5M
- 143ARMPArmata Pharmaceuticals Inc.$103.4M
- 144COEPCoeptis Therapeutics Holdings Inc.$102.1M
- 145HUMAHumacyte Inc.$98.4M
- 146BDTXBlack Diamond Therapeutics Inc.$97.7M
- 147ATRAAtara Biotherapeutics Inc.$96.0M
- 148ELEVElevation Oncology Inc.$94.3M
- 149BHSEBull Horn Holdings Corp.$93.8M
- 150TNYATenaya Therapeutics Inc.$89.0M
- 151AGTCApplied Genetic Technologies Corporation$81.4M
- 152AVROAVROBIO Inc.$80.8M
- 153MIROMiromatrix Medical Inc.$80.6M
- 154PTHSPelthos Therapeutics Inc.$77.5M
- 155CRDFCardiff Oncology Inc.$75.7M
- 156OKYOOKYO Pharma Limited$74.3M
- 157KLDOKaleido Biosciences Inc.$74.1M
- 158CGTXCognition Therapeutics Inc.$73.9M
- 159SGMOSangamo Therapeutics Inc.$73.6M
- 160CSBRChampions Oncology Inc.$66.9M
- 161NMRANeumora Therapeutics Inc.$66.6M
- 162MBOTMicrobot Medical Inc.$66.6M
- 163UPTDTradeUP Acquisition Corp.$58.0M
- 164AXLAAxcella Health Inc.$57.6M
- 165CDTXCidara Therapeutics Inc.$57.4M
- 166INKTMiNK Therapeutics Inc.$52.8M
- 167PSTIPluristem Therapeutics Inc.$52.3M
- 168LONALeonaBio Inc.$50.8M
- 169KLRSKalaris Therapeutics Inc.$50.7M
- 170CRBUCaribou Biosciences Inc.$49.3M
- 171ELOXEloxx Pharmaceuticals Inc.$49.3M
- 172IMAImageneBio Inc.$47.1M
- 173TCONTRACON Pharmaceuticals Inc.$45.1M
- 174XTNTXtant Medical Holdings Inc.$44.7M
- 175INMBINmune Bio Inc.$44.4M
- 176ODTOdonate Therapeutics Inc.$43.1M
- 177EXOZeXoZymes Inc.$42.8M
- 178TVGNTevogen Bio Holdings Inc.$42.4M
- 179TILInstil Bio Inc.$40.4M
- 180PTEPolarityTE Inc.$38.9M
- 181IMRAIMARA Inc.$36.3M
- 182ALGSAligos Therapeutics Inc.$32.7M
- 183ELUTElutia Inc.$32.6M
- 184MGXMetagenomi Therapeutics Inc.$32.5M
- 185GNTAGenenta Science S.p.A.$31.8M
- 186IDRAIdera Pharmaceuticals Inc.$31.1M
- 187BVXVBiondVax Pharmaceuticals Ltd.$30.8M
- 188CYTHCyclo Therapeutics Inc.$30.5M
- 189CVMCel-Sci Corporation$30.1M
- 190WINTWindtree Therapeutics Inc.$30.0M
- 191QNCXQuince Therapeutics Inc.$29.9M
- 192GENEGenetic Technologies Ltd$27.0M
- 193ONVOOrganovo Holdings Inc.$25.4M
- 194EVAXEvaxion A/S$25.3M
- 195SCLXScilex Holding Company$24.2M
- 196BBIBrickell Biotech Inc.$23.8M
- 197ACORAcorda Therapeutics Inc.$19.8M
- 198ATYRaTyr Pharma Inc.$18.0M
- 199JSPRJasper Therapeutics Inc.$16.7M
- 200DYAIDyadic International Inc.$16.4M